Created with Sketch.
Cleveland Clinic Cancer Advances
23 minutes | Dec 2, 2021
Cleveland Clinic's Center for Young-Onset Colorectal Cancer
Suneel Kamath, MD, hematologist and medical oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast for the second time to discuss our new Center for Young-Onset Colorectal Cancer. Listen as Dr. Kamath discusses how the center was established, and how it will allow us to take a comprehensive and multidisciplinary approach to research, diagnosis, and treatment of young-onset colorectal cancer.
22 minutes | Nov 18, 2021
Funding Disparities Affecting Cancers with High Mortality Rates
Hematologist and medical oncologist at Cleveland Clinic Cancer Center, Suneel Kamath, MD, joins the Cancer Advances podcast to discuss his research on funding disparities. Many cancers with higher mortality rates and high incidence are underfunded, including colorectal, lung, hepatobiliary and uterine cancers. Listen as Dr. Kamath discusses his research from the American Society of Clinical Oncology (ASCO) 2021 annual meeting, highlighting how critical funding is for advancing cancer research.
22 minutes | Nov 11, 2021
New Developments in Cell Therapy
Paolo Caimi, MD, Associate BMT Director for Cell Therapy at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss new developments and clinical trials in cell therapy. Listen as Dr. Caimi discusses how the field is changing, along with the primary advantages and disadvantages of using cellular therapy compared to chemotherapy.
21 minutes | Nov 4, 2021
Cardio-Oncology for Pediatric and Adult Cancer Patients
Pediatric heart failure and transplant cardiologist at Cleveland Clinic Children's, Shahnawaz Amdani, MD, joins the Cancer Advances podcast to discuss cardio-oncology for both pediatric and adult cancer patients who are undergoing chemotherapy or have completed their chemotherapy and are now long-term survivors. Listen as Dr. Amdani highlights when and how cardiac toxicity develops, preventative therapies and how the field has evolved.
16 minutes | Oct 28, 2021
Triple-Negative Breast Cancer Prevention Vaccine
Cleveland Clinic recently opened a clinical trial to determine the maximum tolerated dose of a vaccine in patients with non-metastatic triple-negative breast cancer (TNBC). The breast cancer vaccine was invented and developed by Cleveland Clinic immunologist Vincent Tuohy, PhD, and his research team. Cleveland Clinic medical oncologist and principal investigator, G. Thomas Budd, MD, joins the Cancer Advances podcast to discuss the trial origins and what we are looking to accomplish.
19 minutes | Oct 21, 2021
Our Approach to Community Outreach
Miriam Hernandez, Program Manager in Community Outreach at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to talk about our approach to community outreach and how we’re helping to educate and provide cancer screenings for the underserved population. Listen as Miriam highlights how the community outreach program initially started, what initiatives they are actively doing within the community, and how they are making a difference.
19 minutes | Aug 19, 2021
Liver Tumor Ablation
Cleveland Clinic is the first hospital in the world to use an FDA-approved ablation technology that can destroy large liver tumors. Director of Cleveland Clinic's Surgical Liver Ablation Program, Eren Berber, MD, joins the Cancer Advances podcast to discuss how the latest technology allows us to treat larger liver tumors more confidently.
18 minutes | Jul 22, 2021
Onco-nephrology is a nascent field. Nephrologist Roman Shingarev, MD, joins the Cancer Advances podcast to discuss Cleveland Clinic's new onco-nephrology program. Listen as Dr. Shingarev talks about the patients he treats, the program he is building, and what’s ahead in this growing field.
23 minutes | Jun 10, 2021
Challenges and Opportunities in Pediatric Sarcoma Care
Pediatric Hematologist-Oncologist at Cleveland Clinic Children's, Peter Anderson, MD, joins the Cancer Advances podcast to talk about the challenges and areas of opportunity in pediatric sarcoma care. Listen as Dr. Anderson covers the importance of multidisciplinary care when managing pediatric sarcoma patients and how virtual visits have become more important than ever.
19 minutes | Feb 18, 2021
Our Integrative Approach to Palliative Care
Cleveland Clinic Cancer Center Hospice and Palliative Care Specialist, Cory Chevalier, MD, joins the Cancer Advances podcast to discuss palliative care. Listen as Dr. Chevalier discusses our unique model in how we integrate palliative care by using a multidisciplinary approach in both an inpatient and clinical setting.
23 minutes | Feb 11, 2021
HIPEC in Gynecologic Cancers
Robert DeBernardo, MD, Section Head of Gynecologic Oncology at Cleveland Clinic Ob/Gyn & Women’s Health Institute joins the Cancer Advances podcast to discuss hyperthermic intra-peritoneal chemotherapy (HIPEC), specifically in gynecologic cancers. Listen as Dr. DeBernardo discusses the procedure and use of HIPEC along with the type of patient and cancers that are ideal for HIPEC treatment.
20 minutes | Dec 10, 2020
Merkel Cell Carcinoma
Brian Gastman, MD, Plastic Surgeon and Medical and Surgical Director of the Melanoma and High-risk Skin Cancer Program at Cleveland Clinic, joins Cancer Advances to discuss the latest in Merkel Cell Carcinoma. He touches on treatment options, research and results, along with what we can expect to see in the coming years.
25 minutes | Nov 25, 2020
Single-Fraction Stereotactic Body Radiation Therapy (SBRT) Effective for Early Stage Lung Cancer
Single-fraction SBRT is safe and effective in treating early stage, medically inoperable NSCLC, according to a ten-year retrospective study of 229 patients, the largest single-institution report to date. Gregory Videtic, MD, radiation oncologist at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the findings that were presented at the American Society for Radiation Oncology (ASTRO) annual meeting.
23 minutes | Nov 12, 2020
The Latest in Breast Cancer Clinical Trials
Jame Abraham, MD, Chair of the Department of Hematology and Medical Oncology at the Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the latest in breast cancer clinical trials. Listen as Dr. Abraham shares his insight on how to get the word out to patients about clinical trials, the role COVID-19 has played in trial logistics, along with which trials he thinks are likely to have the biggest impact in how we treat patients with breast cancer.
18 minutes | Oct 22, 2020
The Latest in Genetic Testing and Screening among Gynecologic Cancer Patients
Genetic testing and screening in gynecologic cancer patients has evolved over the last several years. Miriam AlHilli, MD joins the Cancer Advances podcast to discuss the latest in genetic testing, screening and prevention.
17 minutes | Oct 1, 2020
Breakthroughs in Bladder Cancer Research
Cleveland Clinic Cancer Center oncologist Shilpa Gupta, MD discusses promising findings in the treatment of advanced bladder cancer in this week's Cancer Advances podcast. Dr. Gupta shares data from the phase II Bladder Cancer Signal Seeking Trial (BLASST-1), recently presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium. She also provides an update on additional in-progress clinical trials and what’s on the horizon for bladder cancer research.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021